title: Managing the pharmaceutical industry-health system interface.
abstract: BACKGROUND
  Direct-to-consumer advertising, media, and Internet marketing to physicians and patients, as well as enticing marketing strategies, are used by the pharmaceutical industry to ensure market share growth of new drugs. Our health system adopted a strict vendor policy governing detailing and sampling activities of pharmaceutical representatives, but realized that further analysis of vendor influence in our system was needed.
  
  
  OBJECTIVE
  An assessment of tangible benefits, ethical concerns, and financial liabilities and gains was conducted to reassess the need for further vendor restriction.
  
  
  CONCLUSIONS
  Based on our findings, several recommendations have been made. Medical practices and health systems are encouraged to establish and enforce explicit vendor policies, measure their effectiveness, partner proactively with representatives to deliver a drug-detailing message consistent with system initiatives, monitor and regulate continuing medical education funding, and implement strategies to ensure appropriate drug use.
authors.forename: B J
authors.initials: BJ
authors.lastname: Zarowitz
authors.forename: B
authors.initials: B
authors.lastname: Muma
authors.forename: P
authors.initials: P
authors.lastname: Coggan
authors.forename: G
authors.initials: G
authors.lastname: Davis
authors.forename: G L
authors.initials: GL
authors.lastname: Barkley
mesh_terms: D000329:Advertising; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D004502:Education, Medical, Continuing / Q000191:economics; D004989:Ethics; D006279:Health Maintenance Organizations; D006801:Humans; D008389:Marketing of Health Services / Q000458:organization & administration*; D010819:Physician's Role; D014481:United States